Skip to content

Processa Pharmaceuticals Inc Sustainability Reports

Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation chemotherapy drugs. The company aims to improve the safety-efficacy profile and survival rate for cancer patients who have high unmet medical needs.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 529900A51HZIE4XJB960

FIGI: BBG003MN60F5

3 reports from 2018 to 2023